The report analyzes and forecasts the human growth hormone market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of human growth hormone, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major human growth hormone companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of human growth hormone upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of human growth hormone and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global human growth hormone market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the human growth hormone market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of human growth hormone market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Competitive Landscape
Some of the key players in the global human growth hormone market are Pfizer Inc., Merck KGaA, Eli Lilly and Company, Novo Nordisk A/S, Novartis AG, Anhui Anke Biotechnology (Group) Co., Ltd, Ipsen S.A., Roche Holdings, Inc., Biopartners GmbH, and GeneScience Pharmaceuticals Co., Ltd.
Key segments of the global human growth hormone market are:
Route of Administration
Distribution Channel
Indication
Geography
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Human Growth Hormone Market, By Application
7.1. Human Growth Hormone Market, By Application Type, 2020-2027
7.1.1. Growth Hormone (GH) Deficiency
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Turner Syndrome
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Idiopathic Short Stature
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Prader-Willi Syndrome
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Small for Gestational Age
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Human Growth Hormone Market, By Distribution Channel
8.1. Human Growth Hormone Market, By Distribution Channel, 2020-2027
8.1.1. Hospital Pharmacy
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Retail Pharmacy
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Online Pharmacy
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Specialty Pharmacy
8.1.4.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Human Growth Hormone Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, By Application (2016-2027)
9.1.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, By Application (2016-2027)
9.1.3.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, By Application (2016-2027)
9.1.4.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, By Application (2016-2027)
9.2.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, By Application (2016-2027)
9.2.3.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, By Application (2016-2027)
9.2.4.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, By Application (2016-2027)
9.2.5.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, By Application (2016-2027)
9.2.6.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, By Application (2016-2027)
9.3.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, By Application (2016-2027)
9.3.3.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, By Application (2016-2027)
9.3.4.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, By Application (2016-2027)
9.3.5.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, By Application (2016-2027)
9.3.6.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, By Application (2016-2027)
9.4.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, By Application (2016-2027)
9.4.3.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, By Application (2016-2027)
9.4.4.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, By Application (2016-2027)
9.4.5.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, By Application (2016-2027)
9.4.6.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, By Application (2016-2027)
9.5.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, By Application (2016-2027)
9.5.3.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, By Application (2016-2027)
9.5.4.2. Market Revenue and Forecast, By Distribution Channel (2016-2027)
Chapter 10. Company Profiles
10.1. Novo Nordisk A/S
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Pfizer Inc.
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Eli Lilly and Company
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Sandoz International GmbH (Novartis AG)
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Merck KGaA
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Genentech, Inc. (Roche)
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Ferring Pharmaceuticals
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Teva Pharmaceutical Industries, Ltd
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Ipsen
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers